Author

Kavisha Arora

Cedars-Sinai Medical CenterORCID 0009-0003-9888-929XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Pathology· 1 Systems Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:statistical model· 1

Frequent Co-Authors

Anjaparavanda P. NareniD· 3 shared Anil Goud JeggaiD· 2 shared Alvin Jay FreemaniD· 1 shared Ameet Shetty· 1 shared Appakalai N. BalamuruganiD· 1 shared Daisuke KiharaiD· 1 shared Danielle HutchingsiD· 1 shared Fanmuyi Yang· 1 shared

Activity by Year

2018-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersBiochemistry

Anjaparavanda P. NarenORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

BiochemistryThe FASEB JournalPeer-reviewedMay 29, 2026

T2R14 mediated antimicrobial responses through interactions with CFTR

Tejas M. Gupte, Nisha Singh, Vikram Bhatia…·Prashen Chelikani

The paper investigates the interaction between T2R14 and CFTR, showing agonist-dependent physical coupling and Gq signaling in response to microbial signals.

1 citation

experimental assaycell signaling & trafficking

𝕏 PostBluesky

PathologybioRxivPreprintMay 25, 2025

Differential Expression and Microsystem Physiology Reveal Predominant and Drug Reversible CFTR-Related Defects in Idiopathic Pancreatitis

Paba Edisuriya, Pramodha S. Liyanage, Jesun Lee…·Kavisha Arora

This study identifies CFTR-related defects in idiopathic pancreatitis and shows that ivacaftor can reverse these defects in patient-derived models.

DOI 10.1101/2025.05.25.656006

humanbulk RNA-seq

𝕏 PostBluesky

Systems BiologybioRxivPreprintMar 24, 2018

PP-2, a src-kinase inhibitor, is a potential corrector for F508del-CFTR in cystic fibrosis

Yunguan Wang, Kavisha Arora, Fanmuyi Yang…·Anil Goud Jegga

The paper identifies PP-2, a src-kinase inhibitor, as a novel corrector for ΔF508-CFTR in cystic fibrosis through in silico screening and experimental validation.

4 citations

humanbulk RNA-seq

𝕏 PostBluesky